BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17303014)

  • 1. High-grade T1 bladder cancer at the ureterovesical junction.
    Soloway M
    Curr Urol Rep; 2007 Mar; 8(2):104-7. PubMed ID: 17303014
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 60-year-old man with gross hematuria and flank pain.
    Miller ET; Aronson WJ; Bassett JC
    Urology; 2014 Jun; 83(6):1233-5. PubMed ID: 24231218
    [No Abstract]   [Full Text] [Related]  

  • 4. Transurethral partial cystectomy with continuous wave laser for bladder carcinoma.
    Yang Y; Wei ZT; Zhang X; Hong BF; Guo G
    J Urol; 2009 Jul; 182(1):66-9. PubMed ID: 19450852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical cystectomy--often too late? 1987.
    Stockle M; Alken P; Engelmann U; Jacobi GH; Riedmiller H; Hohenfellner R
    Eur Urol; 2006 Dec; 50(6):1132-8. PubMed ID: 17183625
    [No Abstract]   [Full Text] [Related]  

  • 7. Radical cystectomy for bladder cancer: morbidity of laparoscopic versus open surgery.
    Guillotreau J; Gamé X; Mouzin M; Doumerc N; Mallet R; Sallusto F; Malavaud B; Rischmann P
    J Urol; 2009 Feb; 181(2):554-9; discussion 559. PubMed ID: 19084856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade transitional cell carcinoma of the pediatric bladder.
    Korrect GS; Minevich EA; Sivan B
    J Pediatr Urol; 2012 Jun; 8(3):e36-8. PubMed ID: 22105002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma and transitional cell carcinoma arising in bladder augmentations.
    Woolsey S; Nambirajan T; Mahendra V; Mulholland C; Kernohan R
    Scand J Urol Nephrol; 2003; 37(3):269-70. PubMed ID: 12775289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of early-invasive high-grade transitional cell carcinoma of the bladder.
    Fritsche HM; Burger M
    Minerva Urol Nefrol; 2008 Dec; 60(4):265-71. PubMed ID: 18923363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
    Stein JP; Penson DF
    BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
    J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
    Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
    Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
    Masood S; Mufti GR
    Urology; 2008 Oct; 72(4):952; author reply 952. PubMed ID: 18926256
    [No Abstract]   [Full Text] [Related]  

  • 15. Some pitfalls in pathological staging of invasive urothelial carcinoma.
    MacLennan GT; Taylor JM
    J Urol; 2004 Oct; 172(4 Pt 1):1464. PubMed ID: 15371871
    [No Abstract]   [Full Text] [Related]  

  • 16. Life-threatening hematuria due to recurrent arterial-conduit fistula.
    Hori S; Thiruchelvam N
    Urology; 2012 Jan; 79(1):23-7. PubMed ID: 22000929
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy.
    Hemal AK; Khaitan A; Dinda AK; Gupta NP; Seth A; Dogra PN; Nabi G
    Urol Int; 2003; 70(1):42-6. PubMed ID: 12566814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Thrasher JB; Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1994 Mar; 73(6):1708-15. PubMed ID: 8156499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.